Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 251-300 of 1147 result(s).
CYDY CytoDyn Inc
04/24/2025 1:07:03 AM
We very possibly own the stadium & (3)
CYDY CytoDyn Inc
04/24/2025 12:17:47 AM
Don't overlook the tumor count pote (3)
CYDY CytoDyn Inc
04/23/2025 8:06:46 PM
Wouldn't THIS be a head spinner: Co (3)
CYDY CytoDyn Inc
04/23/2025 7:35:46 PM
ESMO abstracts are reviewed by the (3)
CYDY CytoDyn Inc
04/22/2025 12:16:28 AM
“My guess is that the FDA may rem (5)
CYDY CytoDyn Inc
04/21/2025 3:13:31 PM
His past interview is 100% in-line (6)
CYDY CytoDyn Inc
04/21/2025 11:33:20 AM
Nobody now @ FDA to protect a crook (1)
CYDY CytoDyn Inc
04/21/2025 11:20:17 AM
Riz...I think...someone said he's a (2)
CYDY CytoDyn Inc
04/21/2025 11:12:46 AM
You're dang right it is ---- " Maka (2)
CYDY CytoDyn Inc
04/21/2025 11:06:53 AM
"...will remove industry representa (3)
CYDY CytoDyn Inc
04/21/2025 10:58:55 AM
The beans are -- all crooked BP's j (4)
CYDY CytoDyn Inc
04/20/2025 10:36:18 PM
"The Food and Drug Administration w (6)
CYDY CytoDyn Inc
04/18/2025 9:26:46 AM
Testimonies 2021 & Prostate stage 4 (5)
CYDY CytoDyn Inc
04/16/2025 9:38:43 PM
Huge from WH on PBM middlemen: The (11)
CYDY CytoDyn Inc
04/14/2025 5:51:17 PM
Long-acting Leronlimab for cancer: (3)
CYDY CytoDyn Inc
04/09/2025 11:10:15 AM
https://www.yahoo.com/finance/news (2)
CYDY CytoDyn Inc
04/09/2025 12:42:53 AM
2023 Trump tariffs for cancer & pha (1)
CYDY CytoDyn Inc
04/09/2025 12:18:00 AM
April 9th, 2025: President Donald T (2)
CYDY CytoDyn Inc
04/09/2025 12:11:50 AM
“We don’t make pharmaceuticals (2)
CYDY CytoDyn Inc
04/08/2025 12:37:18 AM
Max post month ago: While I am not (4)
CYDY CytoDyn Inc
04/08/2025 12:17:41 AM
Inflammation is a central feature o (4)
CYDY CytoDyn Inc
04/07/2025 10:22:46 PM
Dr. J said the ceo did not allow do (2)
CYDY CytoDyn Inc
04/07/2025 9:58:46 PM
You know...other day saw an adverti (3)
CYDY CytoDyn Inc
04/07/2025 9:32:31 PM
Niele: According to estimates, the (4)
CYDY CytoDyn Inc
04/07/2025 1:42:10 AM
An automatic Google result: CytoDyn (7)
CYDY CytoDyn Inc
04/06/2025 7:49:57 PM
Sean007 -- European Society for Med (3)
CYDY CytoDyn Inc
04/06/2025 5:55:59 PM
United States: Breast, lung and bro (7)
CYDY CytoDyn Inc
04/06/2025 10:01:38 AM
CCR5 & bacteria: CCR5 is a receptor (6)
CYDY CytoDyn Inc
04/05/2025 4:43:38 PM
Yep, DOD are always 1st to benefit (2)
CYDY CytoDyn Inc
04/05/2025 12:39:43 AM
Did LL cure Acinetobacter baumannii (7)
CYDY CytoDyn Inc
04/04/2025 8:10:33 PM
Penicillin & Leronlimab: From Scien (2)
CYDY CytoDyn Inc
04/04/2025 5:57:12 PM
NIH: Death rate attributed to NSAID (4)
CYDY CytoDyn Inc
04/04/2025 4:13:41 PM
Leronlimab/ Aspirin/ Penicillin: If (5)
CYDY CytoDyn Inc
04/04/2025 8:27:31 AM
Some types of solid tumors occur on (5)
CYDY CytoDyn Inc
04/03/2025 10:46:30 PM
H.R.1806 - Triple-Negative Breast C (3)
CYDY CytoDyn Inc
04/03/2025 9:20:48 PM
The global oncology drugs market is (5)
CYDY CytoDyn Inc
04/03/2025 3:36:16 PM
Right....& No: SAE's...drug-drug,,d (2)
CYDY CytoDyn Inc
04/03/2025 1:06:40 PM
12 months was Median --- 50/50. Las
CYDY CytoDyn Inc
04/03/2025 1:01:18 PM
No problem ---- they did a trial of (4)
CYDY CytoDyn Inc
04/03/2025 11:51:36 AM
Standard of Care: Trodelvy for mTNB (5)
CYDY CytoDyn Inc
04/02/2025 10:37:21 PM
Cytodyn Inc.'s research suggests th (4)
CYDY CytoDyn Inc
04/02/2025 3:12:43 PM
We've claimed Oncology/solid tumors (9)
CYDY CytoDyn Inc
04/01/2025 10:42:07 PM
Days ago on ST, the data collecting (1)
CYDY CytoDyn Inc
04/01/2025 10:24:44 PM
Thinking on what Bill Gated said ab
CYDY CytoDyn Inc
04/01/2025 2:16:27 PM
Huge overlooked Leronlimab advantag (6)
CYDY CytoDyn Inc
04/01/2025 2:03:23 PM
Website validates March news as ano (3)
CYDY CytoDyn Inc
04/01/2025 11:51:39 AM
Companies are responsible for the s (2)
CYDY CytoDyn Inc
04/01/2025 10:47:47 AM
So, the non-toxic, history making s (1)
CYDY CytoDyn Inc
04/01/2025 9:41:48 AM
TNBC - MOA and combination studies (5)
CYDY CytoDyn Inc
04/01/2025 7:12:33 AM
Yes sir...but did we ever know her (1)
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Oportun's Commitment to Constructive Engagement with Investors
  • IBM and DBmaestro Strengthen Collaboration for Enhanced Database Solutions
  • Tesla's Stock Faces Challenges Amid Renewed Controversy
  • Lumber Liquidators Introduces Innovative InstaCarpet Tile Solution
  • Unlocking Passive Income through Cloud Mining with ETHRANSACTION
  • SC Capital Holding Pursues Luxury Hotel Acquisition in Cyprus
  • Nasdaq Achieves Remarkable Milestone with 142 IPOs in 2025
  • Bob Jahr Takes Charge as CEO of Outlook Therapeutics, Inc.
  • Craig Thompson Joins Esperion's Board, Enhancing Strategy
  • Join Regency Centers for Upcoming Earnings Conference Call
  • Zijin Mining's Strategic $1.2 Billion Gold Acquisition in Asia
  • ZenaTech Expands Defense Tech with New Drone Acquisition Moves
  • Mining Industry Insights: Investment Highlights in Rio Tinto
  • Cohen & Company Securities Unveils New Identity and Expansion
  • Empowering Investors: The Launch of the CAPVX Fund Strategy
  • Nanox Partners with Keiser University for Groundbreaking Imaging Training
  • Nasdaq Reports Surge in IPO Activity for 2025 to Date
  • Celebrate Independence with Exclusive Savings on LG Products
  • Aptose Biosciences Takes a Leap with OTCQB Market Trading
  • Bob Jahr Takes the Helm at Outlook Therapeutics as CEO
  • Arevon Secures Funds to Boost Renewable Energy Initiatives
  • Actelis Networks Secures Key Funding Through Share Offering
  • Esperion Welcomes Craig Thompson to Board of Directors
  • NIO's Increasing Sales Showcase Growth Amid Market Challenges
  • Michael Hutchby's New Role at Marblegate Capital Corporation
  • ECD Automotive Design Celebrates Success with Iconic Builds
  • Top 5 Stock Recommendations From Expert Analysts This Month
  • SenesTech Secures $4.4 Million from Warrant Exercise Deal
  • Indaptus Therapeutics Expands Funding with Major Note Sale
  • Unlocking Monthly Earnings Potential with UniFirst Stock Insights
  • Liberty Waste Solutions Unveils New Brand Identity for Growth
  • Stocks You Should Consider Selling for Better Gains This Quarter
  • Rohrer Aesthetics Revolutionizes Skincare with PIX:E Technology
  • Bounce Empire Launches Groundbreaking Indoor LED Experience
  • Saratoga Investment Corp: Insight on Upcoming Earnings and Forecasts
  • Equinix Schedules Upcoming Call for Quarterly Financial Results
  • Top Stocks Highlighted on CNBC's Halftime Report: Insights
  • Flush Smart Month: Empowering Parents to Foster Good Habits
  • Zoomcar and CARS24: Elevating Self-Drive Car Standards
  • BankFirst Capital Corporation Expands Through Strategic Acquisition
  • Highspring Achieves Prestigious Awards in Staffing Industry
  • Thunder Power's Strategic Move: Share Exchange Agreement Approved
  • Q'Apel Medical Welcomes Stewart Strong as New CEO
  • Gleem Enhances Professional Cleaning Services in NYC
  • Stewart Strong Takes the Helm as CEO of Q'Apel Medical
  • Empowering Your Digital Life: Privacy Help's New Online Resource
  • WHO Collaborates Globally for Sustainable Climate-Health Solutions
  • SharpLink Gaming’s Strategic ETH Expansion and Future Outlook
  • ModifyHealth and Monash University: A New Era for IBS Care
  • American Rebel Holdings Expands 'Rebel Light' Beer Distribution
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site